feed,title,long_url,short_url
SeekingAlpha,Ventyx Biosciences' mid-stage trial of Crohnâ€™s disease treatment did not meet main goal,https://seekingalpha.com/news/4129432,
SeekingAlpha,Innovate announces extension of effective date for reverse stock split,https://seekingalpha.com/news/4129431,
SeekingAlpha,Carmell appoints Kendra Bracken-Ferguson as CEO,https://seekingalpha.com/news/4129430,
SeekingAlpha,Crown Holdings authorizes $2B in stock repurchases,https://seekingalpha.com/news/4129429,
